Medical research articles within Nature

Featured

  • News Feature |

    In 1946, scientists started tracking thousands of British children born during one cold March week. On their 65th birthday, the study members find themselves more scientifically valuable than ever before.

    • Helen Pearson

  • Editorial |

    A Nature survey shows the pernicious impact of activism on biomedical scientists. More institutions must offer researchers the training they need to stand up for their work.

  • Comment |

    Two views on whether scientists who believe that animal experimentation is necessary should become public advocates, or work quietly behind the scenes.

    • Tipu Aziz
    • , John Stein
    •  & Ranga Yogeshwar

  • News & Views |

    Prions are infectious proteins that can cause deadly diseases in mammals. Detailed measurements of infectivity suggest that there may be distinct infectious and toxic versions of this protein. See Letter p.540

    • Reed B. Wickner

  • News & Views |

    Why do some people develop post-traumatic stress disorder, but others emerge from a horrific event relatively unscathed? A molecule involved in orchestrating the brain's response to stress may hold the key to this difference. See Article p.492

    • Murray B. Stein

  • News Feature |

    Nearly one-quarter of biologists say they have been affected by animal activists. A Nature poll looks at the impact.

    • Daniel Cressey

  • News Feature |

    Researcher by day and activist by night, Joseph Harris was leading an untenable double life that eventually landed him in prison.

    • Shanta Barley

  • Books & Arts |

    Peter Border asks how we can protect our personal genomic data while making them available for research.

    • Peter Border

  • Comment |

    Most protein research focuses on those known before the human genome was mapped. Work on the slew discovered since, urge Aled M. Edwards and his colleagues.

    • Aled M. Edwards
    • , Ruth Isserlin
    •  & Frank H. Yu

  • News Feature |

    Theresa Deisher once shunned religion for science. Now, with renewed faith, she is fighting human-embryonic-stem-cell research in court.

    • Meredith Wadman

  • News & Views |

    With the spread of fast-food outlets and more sedentary lifestyles, the prevalence of diabetes in India is rising alarmingly. But the subpopulations at risk and the symptoms of the disease differ from those in the West.

    • Jared Diamond

  • News |

    Heart disorder joins growing list of conditions getting the 'disease in a dish' treatment.

    • Ewen Callaway

  • Comment |

    The dismal patchwork of fragmented research on disease-associated biomarkers should be replaced by a coordinated 'big science' approach, argues George Poste.

    • George Poste

  • News |

    University officials admit data withheld from review panel before misconduct charges arose.

    • Eugenie Samuel Reich

  • News |

    Medical research in the British military soldiers on despite defence cuts.

    • Daniel Cressey

  • Editorial |

    Funding agencies should make researchers reveal industry links.

  • Career Brief |

    Irish partnership gets €19-million government grant for diagnostics R&D.

  • News |

    Replacing genes with drugs could allow safe reprogramming.

    • Ewen Callaway

  • Editorial |

    Germany must better explain the scientific use of animals to remain a major biomedical force.

  • News Feature |

    Bob Klein founded the California Institute for Regenerative Medicine, the biggest state-run research project in US history. What legacy will he leave behind?

    • Elie Dolgin

  • Editorial |

    Moves to price new pharmaceuticals sensibly shouldn't damage the industry's health.

  • Q&A |

    Palestinian researcher heads to Israel to foster scientific exchange.

    • Virginia Gewin

  • News & Views |

    The protein angiotensinogen must undergo conformational changes to be cleaved into a precursor of the hormone angiotensin, which increases blood pressure. Oxidative stress seems to mediate this structural alteration. See Letter p.108

    • Curt D. Sigmund

  • Comment |

    Two months on from the court decision that briefly suspended US federal funding for human embryonic stem-cell research, uncertainty still stalks the field. Here an ethicist, a team of bankers and a lawyer warn of effects of this saga that could be felt for years to come.

  • News |

    Stem-cell researchers targeted by e-mails from unidentified group.

    • Heidi Ledford

  • Career Brief |

    Singapore aims to attract local and international young scientific talent.

Browse broader subjects

Browse narrower subjects

Browse Medical research across other nature.com journals